Northwest Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.05K Hold
146
﹤0.01% 90
2025
Q3
$1.56K Sell
146
-288
-66% -$2.83K ﹤0.01% 237
2025
Q2
$4.2K Buy
434
+1
+0.2% +$10 ﹤0.01% 301
2025
Q1
$6.45K Sell
433
-1,069
-71% -$16.4K ﹤0.01% 337
2024
Q4
$22.4K Buy
1,502
+74
+5% +$1.21K 0.01% 237
2024
Q3
$27.3K Buy
1,428
+2
+0.1% +$41 0.01% 233
2024
Q2
$29.5K Sell
1,426
-58
-4% -$1.15K 0.01% 220
2024
Q1
$27.9K Buy
1,484
+2
+0.1% +$34 0.01% 278
2023
Q4
$21.4K Sell
1,482
-58
-4% -$789 0.01% 294
2023
Q3
$26.7K Buy
1,540
+2
+0.1% +$42 0.01% 253
2023
Q2
$32K Buy
+1,538
New +$33.4K 0.01% 245

Other funds holding OGN

Northwest Capital Management's OGN Position: Q4 2025 in Review

Northwest Capital Management held its Organon & Co (OGN) position steady in Q4 2025 at 146 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #90.

Northwest Capital Management first reported a position in OGN in Q2 2023 and has held it in 11 quarters since. The position peaked at $32K in Q2 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Northwest Capital Management held 146 shares of Organon & Co worth $1.05K as of Q4 2025.
  • Northwest Capital Management left its Organon & Co share count unchanged in Q4 2025.
  • Organon & Co made up ﹤0.01% of Northwest Capital Management's portfolio in Q4 2025, its #90 holding.
  • Northwest Capital Management first reported a position in Organon & Co in Q2 2023 and has held it in 11 quarters since.
  • Northwest Capital Management's Organon & Co position peaked at $32K in Q2 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.